メタ情報
| meta description平均長 | 129.71 |
|---|
| OGPありページ数 | 22 |
|---|
| Twitterカードありページ数 | 22 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 50 |
|---|
| ページあたり内部リンク平均 | 19.87 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| PRD | 1 |
| SOAT1 | 0.853273 |
| patients | 0.79668 |
| was | 0.79668 |
| SOAT2 | 0.711617 |
| PRD001 | 0.666667 |
| HoFH | 0.611111 |
| mouse | 0.59751 |
| MASH | 0.582232 |
| MASLD | 0.582232 |
| NASH | 0.51754 |
| NAFLD | 0.51754 |
| diseases | 0.497925 |
| liver | 0.465422 |
| developing | 0.39834 |
| drugs | 0.39834 |
| reported | 0.39834 |
| were | 0.39834 |
| Outside | 0.39834 |
| PPPA | 0.387851 |
| Therapeutics | 0.323462 |
| other | 0.310281 |
| Founder | 0.310281 |
| lipid | 0.310281 |
| first | 0.310281 |
| selective | 0.310281 |
| have | 0.310281 |
| Participated | 0.310281 |
| 社外取締役 | 0.298755 |
| oral | 0.298755 |
| effective | 0.298755 |
| rare | 0.298755 |
| new | 0.298755 |
| world | 0.298755 |
| only | 0.298755 |
| inhibitors | 0.298755 |
| animal | 0.298755 |
| such | 0.298755 |
| mice | 0.298755 |
| events | 0.298755 |
| director | 0.298755 |
| First | 0.29081 |
| LDL | 0.277778 |
| National | 0.264473 |
| Lipid | 0.264473 |
| Associations | 0.264473 |
| AMED | 0.25877 |
| Human | 0.25877 |
| com | 0.25877 |
| Research | 0.242342 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Minato | Shirokane | 3.774049 | 66 |
| Minato | Tokyo | 3.326477 | 44 |
| Shirokane | Tokyo | 2.985781 | 44 |
| Lipid | National | 2.98403 | 28 |
| Associations | Lipid | 2.957406 | 28 |
| MASH | MASLD | 2.821654 | 32 |
| NAFLD | NASH | 2.624771 | 27 |
| Japan | Tokyo | 2.414953 | 22 |
| Outside | director | 2.401239 | 13 |
| Research | Studio | 2.384402 | 16 |
| AMED | 令和6年度 | 2.360171 | 13 |
| Human試験開始のお知らせ | PRD001のFirst | 2.350544 | 12 |
| Associations | National | 2.315024 | 21 |
| ジャパン | ヘルスケアビジネスコンテスト | 2.311337 | 12 |
| JHeC | ヘルスケアビジネスコンテスト | 2.311337 | 12 |
| First | Human | 2.262167 | 16 |
| other | prd004 | 2.157896 | 10 |
| Dyslipidemia | other | 2.157896 | 10 |
| Human | Study | 2.147856 | 12 |
| lipid | metabolism | 2.147856 | 12 |
| inhibitor | selective | 2.147856 | 12 |
| Japan | Minato | 2.089593 | 22 |
| MASLD | NASH | 2.081528 | 22 |
| fatty | liver | 2.076284 | 13 |
| adverse | events | 2.075704 | 9 |
| LAL | prd003 | 1.997879 | 8 |
| Dyslipidemia | prd004 | 1.997879 | 8 |
| 小林 | 泰良 | 1.997879 | 8 |
| SPARKにてSPARKing | powered | 1.997879 | 8 |
| evaluation | gate | 1.997879 | 8 |
| familial | homozygous | 1.997879 | 8 |
| familial | hypercholesterolemia | 1.997879 | 8 |
| dysfunction | metabolic | 1.997879 | 8 |
| associated | dysfunction | 1.997879 | 8 |
| Series | round | 1.997879 | 8 |
| Annual | Scientific | 1.997879 | 8 |
| Scientific | Sessions | 1.997879 | 8 |
| MRI | PDFF | 1.997879 | 8 |
| businesswire | www | 1.997879 | 8 |
| インベストメンツ株式会社 | グロース | 1.997879 | 8 |
| drugs | new | 1.994478 | 11 |
| First | Initiation | 1.917442 | 12 |
| MASH | NASH | 1.900517 | 20 |
| Japan | Shirokane | 1.858747 | 22 |
| 創薬ベンチャーエコシステム強化事業 | 創薬ベンチャー公募 | 1.847586 | 8 |
| 2025に参加しました | Associations | 1.829843 | 12 |
| mouse | reported | 1.822316 | 12 |
| PRD | Therapeutics | 1.82038 | 20 |
| 細田 | 莞爾 | 1.816768 | 8 |
| 2025に参加しました | 創薬エコシステムサミットに出席しました | 1.816768 | 8 |